FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for esomeprazole magnesium submitted by Cipla USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease
• Helicobacter Pylori Infection
• Nsaid-induced Gastroduodenal Ulcer
• Peptic Ulcer Disease

Drugs mentioned

• Esomeprazole magnesium (esomeprazole magnesium)

Snippet

SUPPL AP for ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE MAGNESIUM)